So we are all familiar with Hashan’s paper written about Neuren in Feb 2022 - A de-risked biotech with 4x upside when he was working for karst peak capital.https://www.livewiremarkets.com/wires/a-de-risked-biotech-with-4x-upside#
Well, he has backed it up, and has now written an updated paper as the founder of KP Rx. You can read it here
https://www.livewiremarkets.com/wires/neuren-where-to-from-here-2024-03-23
So we are all familiar with Hashan’s paper written about Neuren...
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.97 |
Change
0.070(0.35%) |
Mkt cap ! $2.552B | |||
| Open | High | Low | Value | Volume |
| $20.22 | $20.44 | $19.85 | $4.194M | 209.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2772 | $19.93 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.99 | 3310 | 1 |
View Market Depth
| Last trade - 16.10pm 04/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |